The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of GLP1 receptor agonists on survival of breast cancer patients.
 
Tim Prior
No Relationships to Disclose
 
Rachel Tripp
No Relationships to Disclose
 
Natasha Sioda
No Relationships to Disclose
 
Patricia Cronin
No Relationships to Disclose
 
Julie Billar
No Relationships to Disclose
 
Richard Bold
No Relationships to Disclose
 
Lida Mina
Consulting or Advisory Role - AstraZeneca; Lilly
 
Shakeela Bahadur
No Relationships to Disclose
 
Felipe Batalini
Consulting or Advisory Role - Curio Science; Daiichi Sankyo/Astra Zeneca; Illumina/GRAIL; MDoutlook; Merck; Novartis; OncLive/MJH Life Sciences; Prova Health; Stemline Therapeutics
 
Brenda Ernst
No Relationships to Disclose
 
Donald Northfelt
No Relationships to Disclose
 
Karen Anderson
Stock and Other Ownership Interests - FlexBioTech
Consulting or Advisory Role - eFFECTOR Therapeutics
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Molecular diagnostic biomarkers and point of care diagnostic technologies (Inst); RNA therapeutic technologies (Inst)
Travel, Accommodations, Expenses - Dava Oncology
 
Jessica Gayton
No Relationships to Disclose
 
Jessica Fraker
No Relationships to Disclose
 
Soulmaz Boroumand
No Relationships to Disclose
 
Judy Boughey
Honoraria - UpToDate
Consulting or Advisory Role - CairnSurgical; SymBioSis (Inst)
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
Sarah McLaughlin
No Relationships to Disclose
 
Barbara Pockaj
No Relationships to Disclose